Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jul 19, 2026

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
11:05

Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays

Published on: January 7, 2019

在多发性硬化症研究中的竞争利益.

John Noseworthy, Ludwig Kappos, Martin Daumer

    Lancet (London, England)
    |February 1, 2003
    PubMed
    概括

    No abstract available in PubMed .

    关键词:
    生物医学和行为研究研究.

    更多相关视频

    Establishing a Competing Risk Regression Nomogram Model for Survival Data
    04:57

    Establishing a Competing Risk Regression Nomogram Model for Survival Data

    Published on: October 23, 2020

    Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
    05:44

    Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

    Published on: October 13, 2023

    相关实验视频

    Last Updated: Jul 19, 2026

    Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays
    11:05

    Investigation of Genetic Dependencies Using CRISPR-Cas9-based Competition Assays

    Published on: January 7, 2019

    Establishing a Competing Risk Regression Nomogram Model for Survival Data
    04:57

    Establishing a Competing Risk Regression Nomogram Model for Survival Data

    Published on: October 23, 2020

    Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
    05:44

    Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

    Published on: October 13, 2023

    相关概念视频

    您也可能阅读

    相关文章

    通过共同作者、期刊和引用图与本文相关的文章。

    排序
    Same author

    Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis.

    Therapeutic advances in neurological disorders·2023
    Same author

    Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.

    JAMA neurology·2023
    Same author

    A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.

    Journal of magnetic resonance imaging : JMRI·2023
    Same author

    Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.

    European journal of neurology·2023
    Same author

    Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2023
    Same author

    Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.

    Journal of neurology·2023